Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule

Cancer. 1974 Jan;33(1):19-27. doi: 10.1002/1097-0142(197401)33:1<19::aid-cncr2820330107>3.0.co;2-m.
No abstract available

MeSH terms

  • Brain Neoplasms / drug therapy
  • Carcinoma / drug therapy
  • Doxorubicin / administration & dosage*
  • Doxorubicin / adverse effects
  • Doxorubicin / blood
  • Doxorubicin / cerebrospinal fluid
  • Doxorubicin / therapeutic use
  • Doxorubicin / urine
  • Evaluation Studies as Topic
  • Half-Life
  • Hematopoietic System / drug effects
  • Humans
  • Leukemia / drug therapy
  • Liver Diseases / complications
  • Lymphoma / drug therapy
  • Neoplasm Metastasis
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism
  • Remission, Spontaneous
  • Sarcoma / drug therapy

Substances

  • Doxorubicin